Abstract B073: Circulating Tumor Cell (CTC) single cell protein quantification reveals inter-patient heterogeneity in PSMA expression associated with LuPSMA response in a Metastatic Castration Resistant Prostate Cancer (mCRPC) patient cohort
William M. Stump(University of Wisconsin–Madison), Marina N. Sharifi(University of Wisconsin Carbone Cancer Center), Katharine E. Tippins(University of Wisconsin–Madison), Kyle T. Helzer(University of Wisconsin–Madison), Alex H. Chang(University of Wisconsin Carbone Cancer Center), Xiao X. Wei(Dana-Farber Cancer Institute), Jamie M. Sperger(University of Wisconsin–Madison), Grace C. Blitzer(University of Wisconsin–Madison), Kristin L. Rosche(Washington State University), Amy K. Taylor(University of Wisconsin–Madison), Matthew L. Bootsma(University of Wisconsin–Madison), David Kosoff(University of Wisconsin–Madison), Joshua M. Lang(University of Wisconsin–Madison), Emily Abella(University of Wisconsin Carbone Cancer Center), Charlotte Linebarger(University of Wisconsin–Madison), Shannon R. Reese(University of Wisconsin–Madison), Viridiana Carreno(University of Wisconsin Carbone Cancer Center), Muhammad Dar(University of Wisconsin–Madison), Rana R. McKay(University of California San Diego), Kaitlin Durnen(University of Wisconsin–Madison), Shuang G. Zhao(University of Wisconsin–Madison), David Gallo(University of Wisconsin Carbone Cancer Center), John M. Floberg(University of Wisconsin–Madison), Kendra D. Marr(University of Arizona)
Cited by 0
Related Papers
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors
|Proceedings of the National Academy of Sciences|2003|650
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021
|Journal of the National Comprehensive Cancer Network|2021|532